Loading...
Targeting Focal Adhesion Kinase Renders Pancreatic Cancers Responsive to Checkpoint Immunotherapy
Single-agent immunotherapy has achieved limited clinical benefit to date in patients suffering from pancreatic ductal adenocarcinoma (PDAC). This may be due to the presence of a uniquely immunosuppressive tumor microenvironment (TME). Critical obstacles to immunotherapy in PDAC tumors include a high...
Na minha lista:
| Udgivet i: | Nat Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4935930/ https://ncbi.nlm.nih.gov/pubmed/27376576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.4123 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|